Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab.

CONCLUSION: In patients with diabetes with primary trabeculectomy, combined administration of intravitreal bevacizumab and subconjunctival MMC resulted in lower IOP and number of antiglaucoma medication compared with subconjunctival MMC alone.
PMID: 33328187 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - December 16, 2020 Category: Opthalmology Authors: Nilforushan N, Es'haghi A, Miraftabi A, Abolfathzadeh N, Banifatemi M Tags: Br J Ophthalmol Source Type: research